臨床栄養製品市場：製品タイプ、投与経路、用途、地域別、2026年～2032年

臨床栄養製品市場の評価-2026年～2032年

高齢者は慢性疾患や栄養不良に陥りやすいため、高齢化は重要な促進要因となっています。特に先進国で顕著なこの人口動態の変化は、高齢者に合わせた臨床栄養製品に対するニーズの高まりを裏付けています。したがって、高齢者人口の増加は市場規模の成長を急増させ、2024年には408億7,000万米ドルを突破し、2032年には581億2,000万米ドルの評価額に達します。

糖尿病、肥満、がんなどの慢性疾患の有病率は世界的に上昇を続けており、これらの状態を効果的に管理するための標的栄養介入に対する需要が高まっています。したがって、慢性疾患の症例の増加により、市場は2026年から2032年にかけてCAGR 4.50%で成長することが可能です。

臨床栄養製品市場定義/概要

臨床栄養製品は、病状を抱える患者や従来の食事では十分な栄養素を摂取できない患者の特定の食事ニーズを満たすよう、綿密に調整された製剤です。これらの専門的な製品は一般的にヘルスケア専門家によって処方され、患者のニーズや病状に応じて経口、経腸、非経口的に投与されます。経腸栄養製剤は、経鼻胃管や胃瘻などのチューブを介して消化管に直接投与するように設計された液体栄養剤です。経腸栄養剤は、経口的に食物を摂取することはできないが消化器系は機能している患者に使用されます。これらの栄養剤は、吸収されやすい形で必須栄養素を提供するため、患者は健康と回復に必要なカロリー、タンパク質、ビタミン、ミネラルを確実に摂取できます。

非経口栄養法では、静脈を通じて血流に直接栄養を送り込みます。非経口栄養は、消化器系が機能していない、または重度に機能していない患者に用いられます。この方法では、消化管を完全にバイパスして、タンパク質、炭水化物、脂質、電解質などの栄養素を正確に送達することができます。経腸栄養に耐えられない場合や、長期的な栄養補給が必要な場合によく用いられます。医療用食品は、個別の食事管理が必要な特定の病状を有する患者を対象に、特別に処方された食品です。標準的な食品とは異なり、医療用食品は特定の代謝または生理学的ニーズに対応するように設計されています。先天性代謝異常、慢性腎臓病、または胃腸障害などの病態を管理するために使用され、これらの病態の管理をサポートする標的栄養を提供します。

経口栄養補助食品は粉末または液体の形態で入手可能であり、これらの補助食品は患者の通常の食事を補完することを目的としています。十分な量の食事を摂取することが困難な患者、または病気や治療により栄養ニーズが高まっている患者の栄養摂取を強化するために使用されることが多いです。経口栄養補助食品は、全般的な健康、回復、維持をサポートするために、タンパク質、ビタミン、ミネラルを追加摂取することができます。

慢性疾患の増加と消費者意識の高まりが臨床栄養製品市場の成長をどのように押し上げるか？

糖尿病、心臓病、がん、胃腸障害などの慢性疾患の世界の増加が大きな推進力となっています。臨床栄養ソリューションは、これらの症状を効果的に管理するために不可欠なオーダーメイドの治療食を提供します。カスタマイズされた栄養計画は、慢性疾患に関連する特定の食事ニーズに対処するのに役立ち、患者の転帰を改善し、特殊な栄養製品に対する需要を促進します。栄養が健康管理と疾病予防に果たす重要な役割に対する消費者の意識の高まり。栄養が健康全般にどのような影響を及ぼし、疾病予防にどのように役立つのかについて個人の知識が深まるにつれて、臨床栄養製品に対する需要が高まっています。消費者は食事のニーズを満たすために効果的な栄養ソリューションを積極的に求めており、これが市場の成長を後押ししています。

ヘルスケアの進歩にもかかわらず、栄養不良は依然として重大な世界的健康問題であり、あらゆる年齢層の人々に影響を及ぼしています。臨床栄養製品は栄養不良に対処するために不可欠であり、栄養不良は加齢、病状、または不十分な食物摂取によって生じる可能性があります。この持続的な問題は、専門的な栄養介入の必要性を強調し、市場の成長に寄与しています。特に新興市場におけるヘルスケア支出の増加が、臨床栄養製品に対する需要に拍車をかけています。ヘルスケア・インフラおよびサービスへの投資は、病院、診療所、および長期介護施設における臨床栄養製品へのアクセスおよびその必要性を高めています。ヘルスケアサービスに対する資金配分の増加は、臨床栄養市場の拡大を後押ししています。

患者の嗜好、費用対効果、医療技術の進歩などを背景とした在宅ヘルスケアへのパラダイムシフトが、在宅用臨床栄養製品市場を後押ししています。在宅で健康を管理しようという広範な動向を反映して、在宅用に設計された栄養補助食品や経腸栄養製剤の需要が高まっています。世界各国の政府は、公衆衛生戦略の一環として栄養の成果を高めるための政策やイニシアチブを実施しています。治療用栄養製品に対する支持的な規制の枠組みや有利な償還ガイドラインは、市場の拡大を促進します。アクセシビリティ（利用しやすさ）とアフォーダビリティ（購入しやすさ）を促進することで、こうした政府の動きは臨床栄養セクターの成長を刺激します。

製剤および臨床試験に伴う高コストは臨床栄養製品市場の成長をどのように阻害するか？

臨床栄養製品の開発には、臨床試験、製剤の最適化、規制当局の承認取得に関連する多額のコストがかかります。こうした多額の先行投資は、特に特殊な製品やニッチな製品の場合、技術革新や市場参入の阻害要因となります。研究開発の経済的負担は、企業が新しい製剤を模索したり、既存の製品を強化したりする能力を制限し、臨床栄養市場におけるイノベーションを阻害する可能性があります。臨床栄養製品は、さまざまな病状を治療するために設計された代替医薬品との競合に直面しています。製薬会社は、より効果的で信頼性が高いと思われる標的治療薬や医薬品グレードの栄養素を提供することが多いです。ヘルスケアプロバイダーや患者は栄養介入よりも医薬品による治療を好む可能性があり、臨床栄養製品の市場の可能性に影響を与えるため、このような競争は臨床栄養ソリューションの受容と採用を妨げる可能性があります。

臨床栄養製品の有効性は、患者の受容とアドヒアランスに大きく依存します。好ましくない風味、好ましくない食感、または複雑な投与方法などの課題は、これらの製品を一貫して使用する患者の意欲に影響を与えます。アドヒアランスが低いと、栄養介入の全体的な有効性が低下し、潜在的に市場需要が減少し、患者の健康転帰への影響が制限される可能性があります。ヘルスケア予算が制約されている地域または医療費の大部分を患者が負担している地域では、臨床栄養製品の価格が重要な要素となります。ヘルスケア提供者と患者の双方がより手ごろな価格の選択肢を求めるため、コストに敏感であることは、特殊な製品や高級製品に対する需要の減少につながります。価格圧力は、製品開発や技術革新に投資しながら競争力のある価格設定を維持する企業の能力にも影響を与える可能性があります。

知的財産権と特許保護は、臨床栄養市場における競争力を維持するために極めて重要です。企業が革新的な製品の開発に投資する中、特許の失効やジェネリック医薬品やバイオシミラー医薬品の競合他社からの課題は、市場シェアや収益性に影響を与える可能性があります。知的財産の保護は、投資を確保し、市場での優位性を維持するために不可欠ですが、複雑な特許法を理解し、独占権を維持することは困難です。臨床ガイドライン、償還方針、処方決定がさまざまに異なる分断されたヘルスケアシステムは、臨床栄養製品の市場参入を複雑にする可能性があります。企業は、採用や償還を達成するために、複数の利害関係者や意思決定プロセスをナビゲートしなければならないです。このような断片化は市場参入の障壁となり、臨床栄養製品の利用可能性を制限し、全体的な市場浸透と成功に影響を及ぼす可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 臨床栄養製品市場：製品タイプ別

• 乳児栄養
• 経腸栄養
• 非経口栄養
• 栄養補助食品

第5章 臨床栄養製品市場：投与経路別

• 経口栄養サプリメント
• 経腸栄養（経管栄養）
• 非経口栄養（静脈栄養）

第6章 臨床栄養製品市場：用途別

• 栄養不良管理
• 疾患特異的栄養
• スポーツ栄養

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Abbott Nutrition（well-known brands like Ensure, Similac）
• Nestle Health Science
• Baxter Healthcare
• B. Braun Melsungen AG
• Danone（known for Nutricia brand）
• Fresenius Kabi AG
• Mead Johnson Nutrition Company
• Perrigo Company Plc
• Hero Nutritionals Inc.
• Pfizer Inc.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Clinical Nutrition Products Market Valuation - 2026-2032

The aging population is a significant driver, as older adults are more prone to chronic diseases and malnutrition. This demographic shift, particularly pronounced in developed countries, underscores the growing need for clinical nutrition products tailored to the elderly. Thus, the increasing geriatric population surges the growth of market size surpassing USD 40.87 Billion in 2024 to reach a valuation of USD 58.12 Billion by 2032.

The increasing prevalence of chronic diseases such as diabetes, obesity, and cancer continues to rise globally, there is a heightened demand for targeted nutritional interventions to manage these conditions effectively. Thus, the growing cases of chronic diseases enable the market to grow at a CAGR of 4.50% from 2026 to 2032.

Clinical Nutrition Products Market: Definition/ Overview

Clinical nutrition products are meticulously crafted formulations tailored to meet the specific dietary needs of individuals with medical conditions or those who cannot obtain sufficient nutrients through a conventional diet. These specialized products are commonly prescribed by healthcare professionals and can be administered orally, enterally, or parenterally, depending on the patient's needs and medical condition. Enteral nutrition formulas are liquid diets designed to be delivered directly into the gastrointestinal tract via a tube, such as a nasogastric or gastrostomy tube. Enteral nutrition is used for patients who are unable to consume food orally but still have a functioning digestive system. These formulas provide essential nutrients in a form that can be easily absorbed, ensuring that patients receive the necessary calories, proteins, vitamins, and minerals required for their health and recovery.

Parenteral nutrition form of involves delivering nutrients directly into the bloodstream through a vein. Parenteral nutrition is used for patients who have non-functional or severely impaired digestive systems. This method allows for the precise delivery of nutrients such as proteins, carbohydrates, fats, and electrolytes, bypassing the gastrointestinal tract entirely. It is often used in cases where patients cannot tolerate enteral feeding or require long-term nutritional support. Medical foods are specially formulated foods intended for individuals with specific medical conditions that require tailored dietary management. Unlike standard foods, medical foods are designed to address particular metabolic or physiological needs. They may be used to manage conditions such as inborn errors of metabolism, chronic kidney disease, or gastrointestinal disorders, providing targeted nutrition that supports the management of these conditions.

Oral nutritional supplements are available in powdered or liquid form, these supplements are intended to complement a patient's regular diet. They are often used to enhance nutrient intake in individuals who have difficulty consuming sufficient amounts of food or who have increased nutritional needs due to illness or medical treatments. Oral nutritional supplements can provide additional proteins, vitamins, and minerals to support overall health, recovery, and maintenance.

How the Increasing Chronic Disorders and Increasing Consumer Awareness Surge the Growth of Clinical Nutrition Product Market?

The global increase in chronic conditions such as diabetes, heart disease, cancer, and gastrointestinal disorders is a major driver. Clinical nutrition solutions offer tailored therapeutic diets that are crucial for managing these conditions effectively. Customized nutrition plans help address specific dietary needs associated with chronic diseases, improving patient outcomes and driving demand for specialized nutritional products. The growing consumer awareness of the critical role nutrition plays in managing health and preventing illnesses. As individuals become more educated about how nutrition impacts their overall well-being and helps in disease prevention, the demand for clinical nutrition products rises. Consumers are actively seeking effective nutritional solutions to meet their dietary needs, which is propelling market growth.

Despite advancements in healthcare, malnutrition remains a significant global health issue, affecting people of all ages. Clinical nutrition products are essential for addressing malnutrition, which can result from aging, medical conditions, or insufficient food intake. This persistent issue underscores the need for specialized nutritional interventions and contributes to market growth. Rising healthcare spending, particularly in emerging markets, is fueling the demand for clinical nutrition products. Investments in healthcare infrastructure and services enhance access to and the need for these products in hospitals, clinics, and long-term care facilities. The growing allocation of funds towards healthcare services drives the expansion of the clinical nutrition market.

The paradigm shift towards home healthcare, driven by patient preferences, cost-effectiveness, and advancements in medical technology, is boosting the market for home-use clinical nutrition products. Nutritional supplements and enteral feeding formulas designed for home use are increasingly in demand, reflecting a broader trend toward managing health at home. Governments worldwide are implementing policies and initiatives to enhance nutrition outcomes as part of public health strategies. Supportive regulatory frameworks and favorable reimbursement guidelines for therapeutic nutrition products facilitate market expansion. By promoting accessibility and affordability, these government actions stimulate growth in the clinical nutrition sector.

How the High-Cost Associated with Formulation and Clinical Trial Impede the Growth of the Clinical Nutrition Product Market?

The advancement of clinical nutrition products involves significant costs associated with clinical trials, formulation optimization, and obtaining regulatory approvals. These substantial upfront investments are deterrents to innovation and market entry, particularly for specialized or niche products. The financial burden of R&D limit the ability of companies to explore new formulations or enhance existing products, potentially stifling innovation in the clinical nutrition market. Clinical nutrition products face competition from pharmaceutical alternatives designed to treat a wide range of medical conditions. Pharmaceutical companies often offer targeted therapeutics or pharmaceutical-grade nutrients that may be perceived as more effective or reliable. This competition can hinder the acceptance and adoption of clinical nutrition solutions, as healthcare providers and patients might favor pharmaceutical treatments over nutritional interventions, impacting the market potential for clinical nutrition products.

The effectiveness of clinical nutrition products heavily relies on patient acceptance and adherence. Challenges such as unappealing flavors, undesirable textures, or complex administration methods affect patient willingness to use these products consistently. Low adherence can reduce the overall effectiveness of the nutrition interventions, potentially diminishing their market demand and limiting their impact on patient health outcomes. In regions with constrained healthcare budgets or where patients bear a significant portion of healthcare costs, the price of clinical nutrition products becomes a critical factor. Cost sensitivity lead to reduced demand for specialized or premium products, as both healthcare providers and patients seek more affordable options. Price pressures may also impact the ability of companies to maintain competitive pricing while investing in product development and innovation.

Intellectual property rights and patent protection are crucial for maintaining a competitive edge in the clinical nutrition market. As companies invest in developing innovative products, patent expirations or challenges from generic or biosimilar competitors can impact market share and profitability. Protecting intellectual property is essential for securing investment and sustaining market advantages, but navigating the complexities of patent laws and maintaining exclusive rights can be challenging. Fragmented healthcare systems with varying clinical guidelines, reimbursement policies, and formulary decisions can complicate market access for clinical nutrition products. Companies must navigate multiple stakeholders and decision-making processes to achieve adoption and reimbursement. This fragmentation can create barriers to market entry, limit the availability of clinical nutrition products, and affect their overall market penetration and success.

Category-Wise Acumens

How does the Increasing Prevalence of Malnutrition in Adults Surge the Growth of Oral Nutrition Supplements Segment?

The oral nutrition supplement segment is dominating in the clinical nutrition product market. The growing prevalence of malnutrition among adults, combined with the escalating rates of obesity and chronic diseases such as cancer and diabetes, is significantly driving the expansion of the clinical nutrition market. These health challenges have intensified the demand for specialized nutritional solutions designed to address specific dietary needs and support overall health management.

Market leaders and innovators in the clinical nutrition sector are actively engaged in launching new products aimed at improving productivity, durability, and the nutritional quality of their offerings. These advancements are crucial for enhancing the efficacy of clinical nutrition interventions and meeting the diverse needs of patients.

In addition to focusing on nutritional value, manufacturers are increasingly prioritizing the sensory aspects of clinical nutrition products. Recognizing that taste and palatability play a critical role in patient compliance and satisfaction, companies are incorporating a variety of flavors to make their products more appealing. By improving the taste and variety of clinical nutrition products, manufacturers aim to enhance patient adherence and overall effectiveness, thus supporting better health outcomes and driving further market growth.

How does the Broad Spectrum of Products and Diverse Consumer Base Foster the Growth of the Nutritional Supplements Segment?

The nutritional supplements segment hold a dominant position in the clinical nutrition products market, owing to their widespread use and accessibility. The broad spectrum of products such as vitamins, minerals, protein powders, and specialized dietary supplements, catering to various health needs and preferences. Unlike other segments, nutritional supplements are often available over the counter, making them more accessible to a diverse consumer base and enhancing their market reach.

The growing focus on wellness and preventive healthcare further fuels the demand for nutritional supplements. As consumers increasingly seek to proactively manage their health and well-being, the popularity of these products continues to rise. The nutritional supplements are underpinned by their extensive consumer appeal, diverse product offerings, and easy availability. However, it's important to note that other segments, such as infant nutrition and enteral nutrition, are also experiencing notable growth. This rise is driven by specific healthcare needs, demographic changes, and advancements in medical nutrition tailored to particular patient groups.

Country/Region-wise Acumens

How do the Increasing Chronic Diseases and Specialized Nutritional Solutions Surge the Growth of the Clinical Nutrition Product Market in North America?

North America is substantially dominating the clinical nutrition products market. The aging population, which is increasingly vulnerable to chronic diseases and malnutrition, creates a substantial demand for specialized nutritional solutions tailored to older adults. Additionally, the high prevalence of chronic conditions such as diabetes, obesity, and cardiovascular diseases underscores the need for clinical nutrition interventions designed to manage and mitigate these health issues.

Advanced healthcare infrastructure in the region further supports the growth of the clinical nutrition sector, providing a solid foundation for the use of these products. Coupled with high healthcare expenditure, which fuels investment in medical and nutritional advancements, the market benefits from a favorable environment conducive to growth.

The region's early adoption of technological advancements in product development and delivery is another crucial driver. Emphasis on innovation and ongoing research and development efforts aim to create cutting-edge products that address specific nutritional needs effectively. Furthermore, the stringent regulatory framework ensures high standards for the production and distribution of clinical nutrition products, maintaining quality and safety.

These factors collectively contribute to a high penetration rate of clinical nutrition products in the region, surpassing that of other areas. The combination of an aging population, prevalence of chronic diseases, advanced healthcare infrastructure, significant healthcare investments, technological innovation, and strict regulatory oversight positions this region as a leading market for clinical nutrition products.

How the Rising Geriatric Population and Increasing Malnutrition Escalates the Growth of Clinical Nutrition Product Market in Europe?

The region's aging population is increasingly contributing to the demand for specialized nutritional products designed to address age-related health issues and malnutrition. In Addition, the high prevalence of chronic diseases, including cardiovascular conditions, diabetes, and obesity, necessitates effective clinical nutrition interventions to manage and mitigate these health challenges. The advanced healthcare infrastructure across Europe provides a robust framework for the integration and utilization of clinical nutrition products. This well-established healthcare system supports the delivery of specialized nutrition solutions and enhances their accessibility.

Government initiatives across European countries also play a crucial role in fostering market growth. Supportive policies and regulations aimed at improving healthcare and nutrition further drive the demand for clinical nutrition products. The focus on quality and safety is paramount in the region, with stringent regulations ensuring that products meet high standards, thus promoting consumer confidence and market stability.

In addition to these, the growing presence of private-label clinical nutrition products in some European markets reflects a trend toward cost-effective and customized solutions. Despite the market's maturity, characterized by established players and a stable market environment similar to North America, ongoing innovation and regulatory support continue to drive growth and evolution in the European clinical nutrition sector.

Competitive Landscape

The Clinical Nutrition Products Market is highly competitive, with a mix of established global players and regional competitors. The industry is characterized by intense R&D efforts, strong distribution networks, and a focus on product differentiation.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the clinical nutrition products market include:

• Abbott Nutrition (well-known brands like Ensure, and Similac)
• Nestle Health Science
• Baxter Healthcare
• Braun Melsungen AG
• Danone (known for the Nutricia brand)
• Fresenius Kabi AG
• Mead Johnson Nutrition Company
• Perrigo Company Plc
• Hero Nutritionals, Inc.
• Pfizer, Inc.
• Clinical Nutrition Products Market Latest Developments:
• In August 2020, Nestle Health Science, a company of Nestle SA, announced the agreement ot acquire IM HealthScience. IM HealthScience offers medical nutrition products that address particular dietary needs for a variety of conditions. This tactical acquisition allowed the company to develop and diversify its portfolio of nutritional management products.
• In July 2020, Danone announced an investment of $108 million in the expansion of its specialty nutrition products in China. This investment allowed the company to expand the range of nutritional products it provides to better serve Chinese consumers and reclaim the country's clinical nutrition market share.

Clinical Nutrition Products Market, By Category

• Product Type:
• Infant Nutrition
• Enteral Nutrition
• Parenteral Nutrition
• Nutritional Supplements
• Route of Administration:
• Oral Nutrition Supplements
• Tube Feeding
• Intravenous Feeding
• Application:
• Malnutrition Management
• Disease-specific Nutrition
• Sports Nutrition
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Clinical Nutrition Products Market, By Product Type

• Infant Nutrition
• Enteral Nutrition
• Parenteral Nutrition
• Nutritional Supplements

5. Clinical Nutrition Products Market, By Route of Administration

• Oral Nutrition Supplements
• Enteral Nutrition (Tube Feeding)
• Parenteral Nutrition (Intravenous Feeding)

6. Clinical Nutrition Products Market, By Application

• Malnutrition Management
• Disease-specific Nutrition
• Sports Nutrition

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Nutrition (well-known brands like Ensure, Similac)
• Nestle Health Science
• Baxter Healthcare
• B. Braun Melsungen AG
• Danone (known for Nutricia brand)
• Fresenius Kabi AG
• Mead Johnson Nutrition Company
• Perrigo Company Plc
• Hero Nutritionals Inc.
• Pfizer Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References